Sep 2026
Development and validation of a preoperative 18F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study.
The 18F-PSMA-1007 PET/MR model provided externally validated prognostic information and showed incremental value beyond CAPRA-S at 3 years, which is required before it can guide secondary-treatment decisions.
Jia-Jia Hu, Hangxing Chunyu, Yi-Hong Yang et al.
· European Journal of Nuclear... · 0 citations